SCHEMBL1490278

SCHEMBL1490278

Cc1ccc(-c2scc(NC(=O)c3nc4ccccc4o3)c2C(=O)O)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
RAB9A P51151 3/20 0.41
FAAH O00519 1/20 0.39
KDM4E B2RXH2 4/20 0.38
MAPK1 P28482 2/20 0.38
MAPT P10636 3/20 0.38
ALDH1A1 P00352 5/20 0.37
HPGD P15428 5/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 5/20 0.37
MEN1 O00255 4/20 0.37
TP53 P04637 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
BUB1 O43683 1/20 0.35
USP2 O75604 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490260 0.89 RAB9A (0.41) NPC1RAB9AFAAHKDM4EMAPT
SCHEMBL12829829 0.86 MAPT (0.42) NPC1RAB9AFAAHKDM4EMAPT
SCHEMBL12831077 0.85 KMT2A (0.42) NPC1RAB9AFAAHKDM4EMAPT
SCHEMBL12830472 0.84 SRPK1 (0.44) NPC1RAB9AFAAHKDM4EMAPT
SCHEMBL12756337 0.84 GRM2 (0.40) NPC1RAB9AFAAHKDM4EMAPT
SCHEMBL12830474 0.84 TP53 (0.39) NPC1RAB9AFAAHMAPTKMT2A
SCHEMBL12830464 0.84 HPGD (0.38) NPC1RAB9AFAAHKDM4EMAPK1
SCHEMBL2180967 0.83 MEN1 (0.46) NPC1RAB9AFAAHMAPK1MAPT
SCHEMBL12756333 0.83 FAAH (0.39) NPC1RAB9AFAAHKDM4EMAPT
SCHEMBL12756356 0.83 KMT2A (0.41) NPC1RAB9AFAAHKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 US disclosed
EP-2477982-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2012-07-25 EP disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885FAAH 1909/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885FAAH 1909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.